News Wire
LIVEReal-time CBD & hemp news from 16+ industry sources. Updated every 2 hours.
287 stories6 sources
Cannabidiol potentiates p53-driven autophagic cell death in non-small cell lung cancer following DNA damage: a novel synergistic approach beyond canonical pathw...
Congressional hearing on FDA and CBD zeroes in on intoxicating hemp products HempToday
House Republicans repeat hemp-derived THC grievances during FDA hearing MJBizDaily
Hemp Industry Expert Tells Congress Businesses Are 'Begging' For Federal Regulations At FDA-Focused Committee Hearing Marijuana Moment
FDA clarifies regulatory stance on use of CBD Nation’s Restaurant News
FDA Wants To Add Hemp-Derived Cannabinoid Product Option To Federal Form About Negative Consumer Experiences Marijuana Moment
The molecular anti-metastatic potential of CBD and THC from Lebanese Cannabis via apoptosis induction and alterations in autophagy Nature
Senate Democrat unveils legislation giving FDA oversight on CBD safety standards The Hill
The FDA’s Continued Search for a Legal Pathway for CBD Products Reed Smith LLP
FDA Continues to Take Stance That it Will Not Issue CBD Rules Foley & Lardner LLP
CBD advocate asks for Legion support with legislation to create FDA regulation The American Legion
Convergence: FDA looking for ‘a new way forward’ on CBD regulation Regulatory Affairs Professionals Society | RAPS
Hearing Wrap Up: FDA’s Failure to Regulate CBD Threatens Consumer Access to Safe Products House.gov
Congressional Leaders Seek Stakeholder Input Regarding CBD Regulation Holland & Knight
Key Republicans nix idea to give FDA new power to regulate CBD statnews.com
Ranking Member Raskin’s Opening Statement at Subcommittee Hearing Examining Regulation of Hemp-Derived and CBD Products House Oversight Democrats (.gov)
McClain: FDA Must Use Existing Authorities to Regulate Hemp-Derived Products House.gov
CBD: Does it work? Is it safe? Is it legal? AAMC
FDA, USP Advance Standardization, Regulation of Cannabis Nationally Pharmacy Times
FDA Shares Insights on Potential Pathway to Regulate CBD Products | Cannabis & the Law Foley Hoag